source
- Webinar explores how GLP-1 obesity drugs are reshaping US healthcare and market dynamicsThe upcoming webinar titled "The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets" will examine how GLP-1 receptor agonists used for obesity are altering the U.S. health-care landsc…
- BMS reports positive mid-stage results for arlo-cel in heavily pre-treated myeloma patientsBMS said its CAR T therapy arlo-cel, formally arlocabtagene autoleucel, achieved positive results in a registrational mid-stage study for relapsed and refractory multiple myeloma. The open-label,…